Researchers at the University of California, Davis have discovered an association between Alzheimer’s disease and the presence of Gram-negative bacterial molecules in brain tissue.
Most medications made to treat Alzheimer’s disease (AD) aim to help improve memory or slow the development of symptoms. Others attempt to suppress the behavioral issues associated with the disease. However, none of these medications treat the cause of AD or prevent further brain damage.
Researchers at the University of California, Davis have discovered an association with bacterial molecules and AD neuropathology. Based on this correlation, a vaccine treatment has been proposed against the bacterial infection that may prevent or delay AD progress.
Country | Type | Number | Dated | Case |
United States Of America | Issued Patent | 11,598,774 | 03/07/2023 | 2017-127 |
Alzheimer’s disease, amyloid plaques